Arvinas

Arvinas

World Rank (Aug-2026)
11627
Market Cap (Aug-2026)
0.587 Billion USD
Market Cap (Mar-08-2026)
0.870 Billion USD
World Rank (Jan-05-2024)
5,263
Market Cap (Jan-05-2024)
2.279 Billion USD
World Rank (Jul-30-2023)
7,862
Market Cap (Jul-30-2023)
1.197 Billion USD
World Rank (Jan-07-2022)
4,198
Market Cap (Jan-07-2022)
3.646 Billion USD
World Rank (Jan-01-2021)
3,492
Market Cap (Jan-01-2021)
4.017 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
ARVN
Employee Count
280
Employee Count as of Date
As on 2021
Headquarters City/State
Connecticut
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
263 Million USD
Annual Operating Income in USD
-119 Million USD
Annual Net Income in USD
-81 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
718 Million USD
Total Liabilities in USD
284 Million USD
Total Equity in USD
434 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
ARVINAS
Yahoo
Yahoo @ Nasdaq
Company Profile

Arvinas is a Clinical Stage Biopharmaceutical company. It is focused on developing new therapeutics for cancers and other difficult to treat diseases and on high value targets in cancer including the androgen and estrogen receptors associated with prostate and breast cancers, respectively. The headquarters is in USA.

Annual Results Summary

ARVINAS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022131-263 (Loss)-282 (Loss)
Dec-202146-195 (Loss)-191 (Loss)
Dec-202021-124 (Loss)-119 (Loss)
Dec-201942-51 (Loss)-70 (Loss)
Dec-201814-43 (Loss)-239 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,268 Million USD.

Total Liabilities as on Dec-2022 was 703 Million USD.

Total Equity as on Dec-2022 was 564 Million USD

Founded Year
2013
IPO Year
2018
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share